CHRISTINA HENDRICKS: Open Payments
NPI 1407917099 · CLIVE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,285 in 86 payments from 11 companies in 2025. Trend: 2023 $1,210 · 2024 $1,372 · 2025 $1,285
Food & beverage: $1,285
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $495 |
| Takeda Pharmaceuticals U.S.A., Inc. | 26 | $291 |
| Phathom Pharmaceuticals, Inc. | 4 | $137 |
| Lilly USA, LLC | 5 | $106 |
| Regeneron Healthcare Solutions, Inc. | 5 | $87 |
| PFIZER INC. | 4 | $66 |
| Aimmune Therapeutics, Inc. | 2 | $37 |
| Madrigal Pharmaceuticals | 1 | $20 |
| Ardelyx, Inc. | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: CREON, EOHILIA, RINVOQ, VOQUEZNA, LINZESS, OMVOH, DUPIXENT, ENTYVIO.
Industry payments across IA — which companies pay providers there.
